These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23146500)

  • 1. Assessment of nonimmunologic factors in kidney transplant recipients according to Kidney Disease Improving Global Outcomes.
    Dounousi E; Mitsis M; Spanos G; Pappas C; Koutlas V; Tzalavra I; Xarisis C; Glantzounis G; Fatouros M; Siamopoulos KC
    Transplant Proc; 2012 Nov; 44(9):2709-11. PubMed ID: 23146500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
    Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic renal failure complications and management in kidney transplanted and nontransplanted patients.
    Kaysi S; Hadj Abdelkader M; Aniort J; Garrouste C; Philipponnet C; Deteix P; Heng AE
    Transplant Proc; 2012 Dec; 44(10):2997-3000. PubMed ID: 23195013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing levels of hemoglobin improve renal transplantation outcomes.
    Lofaro D; Greco R; Papalia T; Bonofiglio R
    Transplant Proc; 2011 May; 43(4):1036-8. PubMed ID: 21620046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
    Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?
    Jiménez Alvaro S; Marcén R; Teruel JL; Fernández Rodríguez A; Pascual J; Galeano C; Villacorta J; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2409-11. PubMed ID: 19715935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
    Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
    Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
    Verdalles U; García de Vinuesa S; Goicoechea M; Gómez Campderá F; Luño J
    Nefrologia; 2007; 27(3):320-8. PubMed ID: 17725451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: the AnemiaTrans Study.
    Sánchez-Fructuoso AI; Ruiz JC; Torregrosa JV; González E; Gómez E; Gallego RJ; Troya MI; Jimenez C; Llamas F; Romero R; Bernis C; Crespo JF; Guirado L;
    Adv Ther; 2012 Nov; 29(11):979-91. PubMed ID: 23160946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?
    Malyszko J; Glowinska I; Mysliwiec M
    Transplant Proc; 2012 Dec; 44(10):3013-6. PubMed ID: 23195016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria is a predictor of posttransplant anemia.
    Bonofiglio R; Lofaro D; Greco R; Senatore M; Papalia T
    Transplant Proc; 2011 May; 43(4):1063-6. PubMed ID: 21620053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dyslipidemia and the risk of kidney disease].
    Ligabue G; Cavazzini F; Albertazzi A
    G Ital Nefrol; 2007; 24 Suppl 38():8-12. PubMed ID: 17922441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease is still present after renal transplantation with excellent function.
    Bertoni E; Rosati A; Larti A; Merciai C; Zanazzi M; Rosso G; Gallo M; Marcucci R; Salvadori M
    Transplant Proc; 2006 May; 38(4):1024-5. PubMed ID: 16757252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.
    Fernandez Fresnedo G; Franco Esteve A; Gómez Huertas E; Cabello Chaves V; Díz Gómez JM; Osorio Moratalla JM; Gallego Samper R; Gallego Valcárcel E; Campistol Plana JM; Marín Iranzo R; Arias Rodríguez M;
    Transplant Proc; 2012 Nov; 44(9):2601-2. PubMed ID: 23146468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement.
    Heemann U; Abramowicz D; Spasovski G; Vanholder R;
    Nephrol Dial Transplant; 2011 Jul; 26(7):2099-106. PubMed ID: 21555392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of anemia in patients with chronic kidney disease.
    McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
    Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progression factors in chronic kidney disease. Non-immunological mechanisms].
    Fernández Fresnedo G; Sánchez Plumed J; Arias M; Del Castillo Caba D; López Oliva MO
    Nefrologia; 2009; 29 Suppl 1():16-24. PubMed ID: 19675657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum phosphorus level with anemia in kidney transplant recipients.
    Kovesdy CP; Mucsi I; Czira ME; Rudas A; Ujszaszi A; Rosivall L; Kim SJ; Wolf M; Molnar MZ
    Transplantation; 2011 Apr; 91(8):875-82. PubMed ID: 21358369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.